Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-03-08 @ 11:26 PM
Study NCT ID:
NCT03219333
Status:
COMPLETED
Last Update Posted:
2024-08-27
First Post:
2017-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-13
First Submit QC Date:
None
Study First Post Date:
2017-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-26
Results First Submit QC Date:
None
Results First Post Date:
2021-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-22
Last Update Post Date:
2024-08-27
Last Update Post Date Type:
ACTUAL